CITIGROUP INC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 100 filers reported holding CUE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$80
-99.8%
35
-99.7%
0.00%
Q2 2023$37,566
+3656.6%
10,292
+3198.7%
0.00%
Q2 2022$1,000
-90.0%
312
-84.5%
0.00%
Q1 2022$10,000
-98.9%
2,016
-97.5%
0.00%
Q4 2021$907,000
+120.7%
80,185
+184.3%
0.00%
Q3 2021$411,000
-57.5%
28,205
-66.1%
0.00%
-100.0%
Q2 2021$968,000
+6.8%
83,125
+12.0%
0.00%0.0%
Q1 2021$906,000
+1108.0%
74,237
+1139.6%
0.00%
Q4 2020$75,000
+108.3%
5,989
+147.4%
0.00%
Q3 2020$36,000
-96.8%
2,421
-94.7%
0.00%
-100.0%
Q2 2020$1,128,000
+1211.6%
46,011
+658.1%
0.00%
Q1 2020$86,000
+32.3%
6,069
+49.3%
0.00%
Q4 2019$65,000
-46.3%
4,064
-71.7%
0.00%
Q3 2019$121,000
-20.4%
14,340
-15.2%
0.00%
Q2 2019$152,000
+16.9%
16,910
+0.6%
0.00%
Q1 2019$130,000
+62.5%
16,802
-2.3%
0.00%
Q4 2018$80,000
-63.0%
17,194
-27.8%
0.00%
Q3 2018$216,000
-15.3%
23,813
+10.8%
0.00%
Q2 2018$255,000
-67.6%
21,500
-61.7%
0.00%
-100.0%
Q1 2018$788,00056,0640.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,915,219$23,959,0005.70%
Prosight Management, LP 906,569$11,341,0005.24%
P.A.W. CAPITAL CORP 140,000$1,751,0001.54%
Voss Capital, LLC 220,714$2,761,0001.39%
Robertson Stephens Wealth Management, LLC 484,000$6,054,0001.26%
Slate Path Capital LP 1,483,619$18,560,0001.00%
Nantahala Capital Management 2,506,772$31,360,0000.97%
PRECEPT MANAGEMENT LLC 150,000$1,877,0000.76%
SANDERS MORRIS HARRIS LLC 193,591$2,449,0000.56%
Rock Creek Group, LP 100,014$1,251,0000.51%
View complete list of CUE BIOPHARMA INC shareholders